Free Trial

Corporate Dollar Issuance Starting to Launch

PIPELINE

Still waiting on Bristol-Myers, Norfolk Southern and Enbridge, guidance updated

  • Date $MM Issuer (Priced *, Launch #)
  • 02/15 $1.5B #Enbridge $400M 2Y +63, $600M 2Y FRN/SOFR+63, $500M 3Y +73
  • 02/15 $1B Factset WNG 5Y +100, 10Y +145
  • 02/15 $Benchmark Bristol-Myers 10Y +115a, 20Y +140a, 30Y +155a, 40Y +170a
  • 02/15 $Benchmark Norfolk Southern 10Y +95, 31Y +135
  • 02/15 $500M #Israel Electric Corp WNG 10Y +175
  • 02/15 $400M #Kemper 10Y +180

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.